STOCKHOLM, SE / ACCESS Newswire / March 28, 2025 /Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), today ...
STOCKHOLM, SE / ACCESS Newswire / March 28, 2025 / Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), today annou ...
Plus Therapeutics Inc (PSTV) reports promising clinical progress and strategic funding, despite financial hurdles in its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback